Hepatic stellate cells directly inhibit B cells via programmed death-ligand 1

Journal of Immunology

Volumn 196, Issue 4, 2016, Pages 1617-1625

  Li, Yan ^a   Lu, Lina ^a   Qian, Shiguang ^a   Fung, John J ^a   Lin, Feng ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(4-HYDROXY-3-NITROPHENYL)ACETYL-FICOLL; CD274 PROTEIN, MOUSE; FICOLL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR;

ANALOGS AND DERIVATIVES; ANIMAL; B LYMPHOCYTE; BLOOD; C57BL MOUSE; GENETICS; HEPATIC STELLATE CELL; HOMEOSTASIS; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER; LYMPHOCYTE ACTIVATION; METABOLISM; SPLEEN;

ANIMALS; ANTIGENS, CD274; B-LYMPHOCYTES; FICOLL; HEPATIC STELLATE CELLS; HOMEOSTASIS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVER; LYMPHOCYTE ACTIVATION; MICE, INBRED C57BL; MICE, KNOCKOUT; PROGRAMMED CELL DEATH 1 RECEPTOR; SPLEEN;

EID: 84958559591     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501737     Document Type: Article

References (48)

1. Kamada, N., H. S. Davies, and B. Roser. 1981. Reversal of transplantation immunity by liver grafting. Nature 292: 840-842.
2. Qian, S., A. J. Demetris, N. Murase, A. S. Rao, J. J. Fung, and T. E. Starzl. 1994. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 19: 916-924.
3. Zimmermann, F. A., H. S. Davies, P. P. Knoll, J. M. Gokel, and T. Schmidt. 1984. Orthotopic liver allografts in the rat. The influence of strain combination on the fate of the graft. Transplantation 37: 406-410.
4. Kamada, N., G. Brons, and H. S. Davies. 1980. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 29: 429-431.
5. Orlando, G., S. Soker, and K. Wood. 2009. Operational tolerance after liver transplantation. J. Hepatol. 50: 1247-1257.
6. Ramos, H. C., J. Reyes, K. Abu-Elmagd, A. Zeevi, N. Reinsmoen, A. Tzakis, A. J. Demetris, J. J. Fung, B. Flynn, J. McMichael, et al. 1995. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 59: 212-217.
7. Devlin, J., D. Doherty, L. Thomson, T. Wong, P. Donaldson, B. Portmann, and R. Williams. 1998. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology 27: 926-933.
8. Lumsden, A. B., J. M. Henderson, and M. H. Kutner. 1988. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 8: 232-236.
9. Jacob, A. I., P. K. Goldberg, N. Bloom, G. A. Degenshein, and P. J. Kozinn. 1977. Endotoxin and bacteria in portal blood. Gastroenterology 72: 1268-1270.
10. Bumgardner, G. L., M. Heininger, J. Li, D. Xia, J. Parker-Thornburg, R. M. Ferguson, and C. G. Orosz. 1998. A functional model of hepatocyte transplantation for in vivo immunologic studies. Transplantation 65: 53-61.
11. Giampieri, M. P., A. M. Jezequel, and F. Orlandi. 1981. The lipocytes in normal human liver. A quantitative study. Digestion 22: 165-169.
12. Mullhaupt, B., A. Feren, E. Fodor, and A. Jones. 1994. Liver expression of epidermal growth factor RNA. Rapid increases in immediate-early phase of liver regeneration. J. Biol. Chem. 269: 19667-19670.
13. Bissell, D. M., S. S. Wang, W. R. Jarnagin, and F. J. Roll. 1995. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J. Clin. Invest. 96: 447-455.
14. Han, Y. P., L. Zhou, J. Wang, S. Xiong, W. L. Garner, S. W. French, and H. Tsukamoto. 2004. Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen. J. Biol. Chem. 279: 4820-4828.
15. Schaefer, B., A. M. Rivas-Estilla, N. Meraz-Cruz, M. A. Reyes-Romero, Z. H. Hernández-Nazara, J. A. Domínguez-Rosales, D. Schuppan, P. Greenwel, and M. Rojkind. 2003. Reciprocal modulation of matrix metalloproteinase-13 and type I collagen genes in rat hepatic stellate cells. Am. J. Pathol. 162: 1771-1780.
16. Yu, M. C., C. H. Chen, X. Liang, L. Wang, C. R. Gandhi, J. J. Fung, L. Lu, and S. Qian. 2004. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 40: 1312-1321.
17. Chou, H. S., C. C. Hsieh, H. R. Yang, L. Wang, Y. Arakawa, K. Brown, Q. Wu, F. Lin, M. Peters, J. J. Fung, et al. 2011. Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology 53: 1007-1019.
18. Zhang, H., D. B. Stolz, G. Chalasani, and A. W. Thomson. 2013. Hepatic B cells are readily activated by Toll-like receptor-4 ligation and secrete less interleukin-10 than lymphoid tissue B cells. Clin. Exp. Immunol. 173: 473-479.
19. Mehal, W. Z., F. Azzaroli, and I. N. Crispe. 2001. Immunology of the healthy liver: old questions and new insights. Gastroenterology 120: 250-260.
20. Mackay, I. R. 2002. Hepatoimmunology: A perspective. Immunol. Cell Biol. 80: 36-44.
21. Barr, T. A., P. Shen, S. Brown, V. Lampropoulou, T. Roch, S. Lawrie, B. Fan, R. A. O'Connor, S. M. Anderton, A. Bar-Or, et al. 2012. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209: 1001-1010.
22. Issekutz, T., E. Chu, and R. S. Geha. 1982. Antigen presentation by human B cells: T cell proliferation induced by Epstein Barr virus B lymphoblastoid cells. J. Immunol. 129: 1446-1450.
23. Anolik, J. H. 2013. B cell biology: implications for treatment of systemic lupus erythematosus. Lupus 22: 342-349.
24. Dong, H., G. Zhu, K. Tamada, D. B. Flies, J. M. van Deursen, and L. Chen. 2004. B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity 20: 327-336.
25. Chen, C. H., L. M. Kuo, Y. Chang,W. Wu, C. Goldbach, M. A. Ross, D. B. Stolz, L. Chen, J. J. Fung, L. Lu, and S. Qian. 2006. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 44: 1171-1181.
26. Yang, H. R., H. S. Chou, X. Gu, L. Wang, K. E. Brown, J. J. Fung, L. Lu, and S. Qian. 2009. Mechanistic insights into immunomodulation by hepatic stellate cells in mice: A critical role of interferon-gamma signaling. Hepatology 50: 1981-1991.
27. Vazquez, B. N., T. Laguna, J. Carabana, M. S. Krangel, and P. Lauzurica. 2009. CD69 gene is differentially regulated in T and B cells by evolutionarily conserved promoter-distal elements. J. Immunol. 183: 6513-6521.
28. Carrasco, Y. R., and F. D. Batista. 2006. B-cell activation by membrane-bound antigens is facilitated by the interaction of VLA-4 with VCAM-1. EMBO J. 25: 889-899.
29. Agata, Y., A. Kawasaki, H. Nishimura, Y. Ishida, T. Tsubata, H. Yagita, and T. Honjo. 1996. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8: 765-772.
30. Thibult, M. L., E. Mamessier, J. Gertner-Dardenne, S. Pastor, S. Just-Landi, L. Xerri, B. Chetaille, and D. Olive. 2013. PD-1 is a novel regulator of human Bcell activation. Int. Immunol. 25: 129-137.
31. Shih, T. A., M. Roederer, and M. C. Nussenzweig. 2002. Role of antigen receptor affinity in T cell-independent antibody responses in vivo. Nat. Immunol. 3: 399-406.
32. Obukhanych, T. V., and M. C. Nussenzweig. 2006. T-independent type II immune responses generate memory B cells. J. Exp. Med. 203: 305-310.
33. Martin, F., A. M. Oliver, and J. F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14: 617-629.
34. Zeng, Q., Y. H. Ng, T. Singh, K. Jiang, K. A. Sheriff, R. Ippolito, S. Zahalka, Q. Li, P. Randhawa, R. A. Hoffman, et al. 2014. B cells mediate chronic allograft rejection independently of antibody production. J. Clin. Invest. 124: 1052-1056.
35. Bluml, S., K. McKeever, R. Ettinger, J. Smolen, and R. Herbst. 2013. B-cell targeted therapeutics in clinical development. Arthritis Res. Ther. 15(Suppl. 1): S4.
36. Tumanov, A., D. Kuprash, M. Lagarkova, S. Grivennikov, K. Abe, A. Shakhov, L. Drutskaya, C. Stewart, A. Chervonsky, and S. Nedospasov. 2002. Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. Immunity 17: 239-250.
37. Constant, S. L. 1999. B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo. J. Immunol. 162: 5695-5703.
38. Joosten, I., M. C. Baas, E. G. Kamburova, M. W. van den Hoogen, H. J. Koenen, and L. B. Hilbrands. 2014. Anti-B cell therapy with rituximab as induction therapy in renal transplantation. Transpl. Immunol. 31: 207-209.
39. Krumbholz, M., and E. Meinl. 2014. B cells in MS and NMO: pathogenesis and therapy. Semin. Immunopathol. 36: 339-350.
40. Tsai, K. K., and A. I. Daud. 2015. The Role of Anti-PD-1/PD-L1 Agents in Melanoma: Progress to Date. Drugs 75: 563-575.
41. 2015. Nivolumab Approved for Lung Cancer. Cancer Discov. 5: OF1.
42. Nishimura, H., N. Minato, T. Nakano, and T. Honjo. 1998. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int. Immunol. 10: 1563-1572.
43. Lappin, M. B., J. M. Weiss, V. Delattre, B. Mai, H. Dittmar, C. Maier, K. Manke, S. Grabbe, S. Martin, and J. C. Simon. 1999. Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection. Immunology 98: 181-188.
44. Li, Y., Z. Tu, S. Qian, J. J. Fung, S. D. Markowitz, L. L. Kusner, H. J. Kaminski, L. Lu, and F. Lin. 2014. Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis. J. Immunol. 193: 2127-2134.
45. Kurtz, A. 2008. Mesenchymal stem cell delivery routes and fate. Int. J. Stem Cells 1: 1-7.
46. Ponder, K. P., S. Gupta, F. Leland, G. Darlington, M. Finegold, J. DeMayo, F. D. Ledley, J. R. Chowdhury, and S. L. Woo. 1991. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc. Natl. Acad. Sci. USA 88: 1217-1221.
47. Saxena, M., and G. Christofori. 2013. Rebuilding cancer metastasis in the mouse. Mol. Oncol. 7: 283-296.
48. Benten, D., V. Kumaran, B. Joseph, J. Schattenberg, Y. Popov, D. Schuppan, and S. Gupta. 2005. Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat. Hepatology 42: 1072-1081.